v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (9,480) $ (6,172)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 328 324
Amortization of debt (premium) and issuance costs 480 (315)
Amortization of right-of-use assets 396 59
Loss on disposal of fixed assets 326 0
Loss on debt extinguishment 0 (58)
Stock-based compensation expense 322 1,057
Change in fair value of convertible notes for legal services 275 0
Changes in operating assets and liabilities:    
Accounts receivable (396) 879
Prepaids and other current assets 4,148 (1,363)
Other non-current assets 566 153
Accounts payable (245) 716
Accrued liabilities (28) (119)
Accrued interest 24 127
Other current liabilities 31 0
Contract liabilities (3,701) 758
Operating lease liability (120) (191)
Litigation settlement contingency 1,260 0
Other non-current liabilities 0 (30)
Net cash used in operating activities (5,814) (4,175)
Cash flows from investing activities:    
Purchases of property, machinery and equipment (197) 0
Proceeds from sale of property, machinery and equipment 12 0
Net cash used in investing activities (185) 0
Cash flows from financing activities:    
Payment of convertible notes (783) (288)
Proceeds from exercise of warrants 0 2,068
Payments for issuance costs related to exercise of warrants 0 (179)
Repurchase of Section 16 Officer shares for tax coverage exchange 0 (1)
Proceeds from issuance of common stock, pre-funded warrants and related warrants 18,335 5,000
Payments for issuance costs related to common stock, pre-funded warrants and related warrants (826) (599)
Net cash provided by financing activities 16,726 6,001
Increase in cash, cash equivalents and restricted cash 10,727 1,826
Cash, cash equivalents, and restricted cash, beginning of period 12,861 1,572
Cash, cash equivalents, and restricted cash, end of period $ 23,588 $ 3,398